Medication info

Diacartic Acid (Sodium Bicarbonate)

Prescription medicationInjection
Ingredient · strength
Sodium Bicarbonate›650g
Manufacturer / importer
JW Pharmaceutical
Appearance
White crystalline or crystalline powder contained in a polypropylene bottle
Packaging
650g (Plastic bottle)
Approval status
Active

MFDS item code 200603880 · Notified 2006.04.05 · Insurance code 644900641

Summary

Main use
Hemodialysis for renal failure using dialysate preparation; detoxification treatment for poisoning
Who receives it
Adults
Adult administration
1. When the specified acetate-containing dialysate (Solution A) is used, this product can prepare approximately 180L of bicarbonate-type hemodialysis dialysate containing 38mEq/L of HCO_3. 2. Use as dialysate for hemodialysis with a bicarbonate-type dialysate delivery system at a dilution ratio of acetate-containing dialysate (Solution A) 1:(this drug + purified water) 34. 3. The mixing ratio for preparing dialysate for one treatment (based on 6 hours) per patient is as follows. Solution A : (sodium bicarbonate + purified water) =5L(650g + 170L) 4. For general bicarbonate-type hemodialysis, use a dialysate delivery system and adjust the electrolyte concentrations as follows. Na^+ : 140mEq/L HCO_3 : 34mEq/L

Ingredients

Importer
JW Pharmaceutical

Efficacy & effects

Hemodialysis for renal failure using dialysate preparation; detoxification treatment for poisoning

View approved original text

This medication is used to prepare bicarbonate-type dialysis solution during dialysis for patients with acute and chronic renal failure. It is also utilized to prepare dialysis solution when performing hemodialysis on patients with toxic substance poisoning. In this way, it supports the hemodialysis process necessary for the treatment of renal failure and poisoning.

How it is given

Adult administration

1. When the specified acetate-containing dialysate (Solution A) is used, this product can prepare approximately 180L of bicarbonate-type hemodialysis dialysate containing 38mEq/L of HCO_3. 2. Use as dialysate for hemodialysis with a bicarbonate-type dialysate delivery system at a dilution ratio of acetate-containing dialysate (Solution A) 1:(this drug + purified water) 34. 3. The mixing ratio for preparing dialysate for one treatment (based on 6 hours) per patient is as follows. Solution A : (sodium bicarbonate + purified water) =5L(650g + 170L) 4. For general bicarbonate-type hemodialysis, use a dialysate delivery system and adjust the electrolyte concentrations as follows. Na^+ : 140mEq/L HCO_3 : 34mEq/L

Precautions

This medication should not be used in patients with low blood pressure and very rapid heart rate. It should also not be administered to patients with pulmonary edema or abnormal cardiac electrical activity, patients with high serum potassium levels, and patients with coagulation problems. Caution should be exercised in patients with severe liver disease or severe diabetes that may affect metabolism, as this may suppress heart function or cause vascular dilation and low blood pressure. Patients taking digitalis preparations should use this medication carefully to avoid the risk of drug toxicity due to low serum potassium levels. Attention should be given to the use of this medication when serum calcium and phosphorus levels are high before hemodialysis, as this may lead to abnormal calcification. There is a risk of hypoglycemia in patients with insufficient caloric intake or those with diabetes who have dietary restrictions or are taking blood sugar-lowering agents, so caution is warranted. Hypoglycemic symptoms may occur during the use of this medication; if blood sugar drops, appropriate measures such as glucose injection or sugar supplementation should be taken. Since serum calcium levels may increase, it is necessary to switch to a dialysis solution with low calcium levels if hypercalcemia is confirmed. Bone-related complications such as osteoporosis, osteomalacia, and fibrous osteitis may occur, and appropriate treatment such as the administration of active vitamin D_3 preparations may be necessary in such cases. If abnormal calcification occurs, measures to maintain serum phosphorus levels within the normal range, such as the administration of phosphorus binders, are required. During dialysis, symptoms such as headache, nausea, vomiting, seizures, and altered consciousness may occur, and in such cases, it is necessary to take measures such as reducing the dialysis speed. There may be a rapid decrease in blood circulation causing hypotension or symptoms of shock; if these symptoms occur, dialysis should be stopped or the speed reduced, and necessary medications should be administered. This medication is used for hemodialysis in patients with chronic renal failure, especially when it is difficult to improve metabolic acidosis or when symptoms such as low blood pressure or imbalance syndrome occur during the dialysis process. For patients who have difficulty controlling hyperglycemia due to glucose metabolism abnormalities, using this medication without glucose may be helpful. During treatment, it is important to regularly check electrolytes, acid-base balance, blood sugar, and other conditions through blood tests. Pregnant women or those who may become pregnant should only use this medication if the benefits outweigh the risks, as its safety has not been established. The safety for children has not been sufficiently confirmed, so it should be used cautiously in children. Elderly patients should use this medication with careful consideration of its characteristics, and since there is a possibility of bone complications with long-term use, regular examinations and administration of active vitamin D_3 preparations when necessary are needed. For dilution of the dialysis solution, thoroughly purified water should be used, and attention should be paid to damage to the dialysis membrane and tendency for bleeding. When preparing, do not mix the electrolyte solution for artificial kidney dialysis with the sodium bicarbonate solution, and adhere to the specified dilution concentrations. If the dilution concentration is too high or too low, symptoms such as headache, palpitations, blood pressure abnormalities, and altered consciousness may occur, so caution must be exercised. It is preferable to check the electrolyte concentration and pH of the dialysis solution before use, and the diluted dialysis solution should be used immediately. This medication should not be used for injection or peritoneal lavage, and the dialysis solution should be maintained at body temperature during use.

Side effects

  • Hypoglycemia
  • hypercalcemia
  • osteoporosis
  • osteomalacia
  • fibrous osteitis
  • ectopic calcification
  • headache
  • nausea
  • vomiting
  • convulsions
Show 14 more
  • altered consciousness
  • discomfort
  • fatigue
  • hypotension
  • shock symptoms
  • hypertension
  • headache
  • palpitations
  • altered consciousness
  • limb paralysis
  • general fatigue
  • discomfort
  • rapid blood pressure drop
  • altered consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air or moisture. Also, it is important to store it at room temperature below 40 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

White crystalline or crystalline powder contained in a polypropylene bottle

Package unit

650g (Plastic bottle)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.